Skip to content
Austin Top 50
Author:
Vivacta Bio
Vivacta Bio and Grit Bio Announce FDA Orphan Drug Designation for In Vivo CAR-T Therapy GT801 in Autoimmune Hemolytic Anemia
October 17, 2026